Quantcast

Latest Metastasis Stories

2014-07-28 23:01:12

Discovery Accepted into NCI Drug Development Program for Clinical Trials Philadelphia, PA (PRWEB) July 28, 2014 An estimated 68,000 women and men in the U.S. die each year from metastatic breast and prostate cancers – an aggressive form of the disease that occurs when the cancer has spread to other parts of the body, such as the lungs, liver, bones, or brain. Now researchers at Drexel University College of Medicine have developed a compound directed at a target they identified that...

2014-07-23 23:18:30

Transparency Market Research published a new report "Circulating Tumor Cells (CTCs) Prognostic Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store. Browse the full report: http://www.transparencymarketresearch.com/ctcs-prognostic-technologies-market.html Albany, New York (PRWEB) July 22, 2014 According to a new market report published by Transparency Market Research “Circulating Circulating Tumor Cells (CTCs)...

Researchers Discover New Route For Ovarian Cancer Spread
2014-07-15 03:14:42

University of Texas M. D. Anderson Cancer Center HER3-positive circulating tumor cells home in on omentum; new target to thwart metastasis Circulating tumor cells spread ovarian cancer through the bloodstream, homing in on a sheath of abdominal fatty tissue where it can grow and metastasize to other organs, scientists at The University of Texas MD Anderson Cancer Center report in Cancer Cell. "This completely new way of thinking about ovarian cancer metastasis provides new potential...

2014-07-11 10:56:11

Massachusetts General Hospital Circulating tumor cells captured with a microchip-based device developed at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine and the MGH Cancer Center can be cultured to establish cell lines for genetic analysis and drug testing. In the July 11 issue of Science, an MGH research team reports that the cultured cells accurately reflect a tumor's genetic mutation over time and changing susceptibility to therapeutic drugs. "We now...

2014-07-10 12:19:38

Rockefeller University Unexpected links to Alzheimer's disease and Huntington's disease also seen Using an innovative tool that captures heretofore hidden ways that cells are regulated, scientists at Rockefeller University have identified a protein that makes breast cancer cells more likely to metastasize. What's more, the protein appears to trigger cancer's spread in part by blocking two other proteins that are normally linked to neurodegeneration, a finding that suggests these two...

2014-07-09 11:33:39

The Mount Sinai Hospital / Mount Sinai School of Medicine Two genetic mutations in liver cells may drive tumor formation in intrahepatic cholangiocarcinoma (iCCA), the second most common form of liver cancer, according to a research published in the July issue of the journal Nature. A team led by the Icahn School of Medicine at Mount Sinai and Harvard Medical School has discovered a link between the presence of two mutant proteins IDH1 and IDH2 and cancer. Past studies have found IDH...

Treasure Trove Of Genes Key To Kidney Cancer Revealed By Researchers
2014-07-01 03:24:43

[ Watch The Video: Mayo Clinic Researchers Uncovered 31 Genes Key To Development Of Kidney Cancer ] Mayo Clinic A genomic analysis of clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer, from 72 patients has uncovered 31 genes that are key to development, growth and spread of the cancer, say researchers from Mayo Clinic in Florida. Eight of these genes had not been previously linked to kidney cancer, and six other genes were never known to be involved in any...

2014-07-01 11:38:54

IMIM The identification of new therapeutic targets is urgently needed due to the ineffectiveness of current targets Researchers from IMIM (Hospital del Mar Medical Research Institute) have identified a new protein, galectin-1, as a possible therapeutic target for pancreatic cancer. For the first time they have demonstrated the effects of the inhibition of this protein in mice suffering this type of cancer and the results showed an increase in survival of 20%. The work further suggests...

2014-07-01 11:10:06

American Association for Cancer Research A new approach demonstrated that the recognition of unique cancer mutations appeared to be responsible for complete cancer regressions in two metastatic melanoma patients treated with a type of immunotherapy called adoptive T-cell therapy. This new approach may help develop more effective cancer immunotherapies, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. "This study...

2014-06-30 08:30:19

BALTIMORE, June 30, 2014 /PRNewswire/ -- Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, announced today that it has released a new research report on MetaStat, Inc. (OTCQB: MTST). The life sciences company develops and commercializes diagnostic products and novel therapeutics for the early and reliable prediction and treatment of systemic metastasis, the process by which cancer spreads from a primary tumor through the...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related